Literature DB >> 17285797

Non-enzymatic glycation of proteins: a cause for complications in diabetes.

R B Nawale1, V K Mourya, S B Bhise.   

Abstract

Diabetes mellitus is one of the most common non-communicable diseases, and is the fifth leading cause of death in most of the developed countries. It can affect nearly every organ and system in the body and may result in blindness, end stage renal disease, lower extremity amputation and increase risk of stroke, ischaemic heart diseases and peripheral vascular disease. Hyperglycemia in diabetes causes non-enzymatic glycation of free amino groups of proteins (of lysine residues) and leads to their structural and functional changes, resulting in complications of the diabetes. Glycation of proteins starts with formation of Shiff's base, followed by intermolecular rearrangement and conversion into Amadori products. When large amounts of Amadori products are formed, they undergo cross linkage to form a heterogeneous group of protein-bound moieties, termed as advanced glycated end products (AGEs). Rate of these reactions are quite slow and only proteins with large amounts of lysine residues undergo glycation with significant amounts of AGEs. The formation of AGEs is a irreversible process, causing structural and functional changes in protein leading to various complications in diabetes like nephropathy, retinopathy, neuropathy and angiopathy. The present review discusses about role of glycation in various complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17285797

Source DB:  PubMed          Journal:  Indian J Biochem Biophys        ISSN: 0301-1208            Impact factor:   1.918


  11 in total

1.  Genome-wide association study identifies common loci influencing circulating glycated hemoglobin (HbA1c) levels in non-diabetic subjects: the Long Life Family Study (LLFS).

Authors:  Ping An; Iva Miljkovic; Bharat Thyagarajan; Aldi T Kraja; E Warwick Daw; James S Pankow; Elizabeth Selvin; W H Linda Kao; Nisa M Maruthur; Micahel A Nalls; Yongmei Liu; Tamara B Harris; Joseph H Lee; Ingrid B Borecki; Kaare Christensen; John H Eckfeldt; Richard Mayeux; Thomas T Perls; Anne B Newman; Michael A Province
Journal:  Metabolism       Date:  2013-12-04       Impact factor: 8.694

2.  Existence of different structural intermediates and aggregates on the folding pathway of ovalbumin.

Authors:  Afshin Iram; Aabgeena Naeem
Journal:  J Fluoresc       Date:  2011-08-12       Impact factor: 2.217

3.  Papaverine increases human serum albumin glycation.

Authors:  Alireza Ahmadzadeh
Journal:  J Biol Phys       Date:  2014-01-12       Impact factor: 1.365

Review 4.  Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.

Authors:  Erika Guerrero; P Vasudevaraju; Muralidhar L Hegde; G B Britton; K S Rao
Journal:  Mol Neurobiol       Date:  2012-08-26       Impact factor: 5.590

Review 5.  Impact of glycosylation on the unimpaired functions of the sperm.

Authors:  Yong-Pil Cheon; Chung-Hoon Kim
Journal:  Clin Exp Reprod Med       Date:  2015-09-30

6.  Glycation of nail proteins: from basic biochemical findings to a representative marker for diabetic glycation-associated target organ damage.

Authors:  Antoine Sadiki Kishabongo; Philippe Katchunga; Elisabeth H Van Aken; Reinhart Speeckaert; Sabrina Lagniau; Renaat Coopman; Marijn M Speeckaert; Joris R Delanghe
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

7.  Glucose Concentration Affects Fibrin Clot Structure and Morphology as Evidenced by Fluorescence Imaging and Molecular Simulations.

Authors:  Jacob E Hood; Sumith Yesudasan; Rodney D Averett
Journal:  Clin Appl Thromb Hemost       Date:  2018-08-16       Impact factor: 2.389

8.  Computational investigation of inhibitory mechanism of flavonoids as bovine serum albumin anti-glycation agents.

Authors:  Anahita Johari; Ali Akbar Moosavi-Movahedi; Massoud Amanlou
Journal:  Daru       Date:  2014-12-11       Impact factor: 3.117

9.  Long-Term Consumption of Cuban Policosanol Lowers Central and Brachial Blood Pressure and Improves Lipid Profile With Enhancement of Lipoprotein Properties in Healthy Korean Participants.

Authors:  Suk-Jeong Kim; Dhananjay Yadav; Hye-Jeong Park; Jae-Ryong Kim; Kyung-Hyun Cho
Journal:  Front Physiol       Date:  2018-04-24       Impact factor: 4.566

Review 10.  Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA).

Authors:  Peter R Rehani; Hanaa Iftikhar; Motowo Nakajima; Tohru Tanaka; Zaid Jabbar; Riyadh N Rehani
Journal:  J Diabetes Res       Date:  2019-11-06       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.